Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells

Xiaodong Mu1, Christian Isaac, Nicholas Greco

  • 1Stem Cell Research Laboratory, University of Pittsburgh Medical Center , Pittsburgh, PA , USA.

Frontiers in Oncology
|June 28, 2013
PubMed

Insights

The Notch signaling pathway is more active in highly metastatic osteosarcoma (OS) cells, driving aldehyde dehydrogenase (ALDH) activity and promoting cancer spread. Targeting Notch and ALDH may inhibit OS metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis

Background:

  • Osteosarcoma (OS) is the most common bone cancer, with pulmonary metastasis being the primary cause of mortality.
  • The specific molecular mechanisms driving OS metastasis remain poorly understood.
  • Clonally related murine OS cell lines (K7M2 and K12) with differing metastatic potentials offer a valuable model system.

Purpose of the Study:

  • To investigate the role of Notch signaling in the metastatic behavior of osteosarcoma.
  • To explore the relationship between Notch signaling and aldehyde dehydrogenase (ALDH) activity in OS cells.
  • To identify potential therapeutic targets for preventing OS metastasis.

Main Methods:

  • Comparative analysis of Notch gene expression (Notch1, 2, 4) and downstream targets (Hes1, Stat3) in highly metastatic (K7M2) versus less metastatic (K12) OS cells.
  • Assessment of ALDH activity in K7M2 cells following Notch pathway inhibition.
  • In vitro evaluation of Notch signaling's impact on oxidative stress resistance, migration, invasion, and VEGF expression.

Main Results:

  • Notch genes and downstream targets were significantly upregulated in highly metastatic K7M2 cells compared to K12 cells.
  • Notch inhibition led to a reduction in ALDH activity in K7M2 cells.
  • Notch signaling correlated with increased resistance to oxidative stress, enhanced migration and invasion, and elevated VEGF expression, but not proliferation.

Conclusions:

  • Notch signaling pathway activation is associated with increased metastatic potential in osteosarcoma.
  • ALDH activity in OS cells appears to be partially regulated by the Notch pathway.
  • Both Notch and ALDH represent promising molecular targets for therapeutic intervention against osteosarcoma metastasis.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...